Skip to content
Disclosery

Finepoint Capital LP

Follow

13F filer, CIK 1608126, BOSTON, MA

Finepoint Capital LP reported $1,738,519,378 across 9 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000904454-25-000583

Period
2025-09-30
Reported value
$1.74B
Holdings
9
Top 10 weight
100%
New
2
Sold out
3

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RXOnew+7,266,839$112M
QXOadded+1,142,747$21.8M
CLDInew+1,042$1.58K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
LLYVKexited-537,051-$43.6M
SUMMIT HEALTHCARE ACQUISITI…exited-489,999-$19.6K
CALIDI BIOTHERAPEUTICS INCexited-12,499-$2.88K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0000904454-25-000583, largest first. % of portfolio is the value over $542,978,458, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
QXOQXO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 25,750,781 shares; 2024Q4: 24,933,825 shares; 2025Q1: 24,468,160 shares; 2025Q2: 21,152,868 shares; 2025Q3: 22,295,615 shares 22,295,615$425M78.26%+1,142,747Timeline
RXORXO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 7,266,839 shares 7,266,839$112M20.58%newTimeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 961,251 shares; 2024Q4: 961,251 shares; 2025Q1: 961,251 shares; 2025Q2: 961,251 shares; 2025Q3: 961,251 shares 961,251$5.93M1.09%0Timeline
ANNAALEANNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 27,717 shares; 2025Q1: 27,717 shares; 2025Q2: 27,717 shares; 2025Q3: 27,717 shares 27,717$116K0.02%0Timeline
ANNAWALEANNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 490,000 shares; 2025Q1: 490,000 shares; 2025Q2: 490,000 shares; 2025Q3: 490,000 shares 490,000$112K0.02%0Timeline
MNYWWMONEYHERO LIMITEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 895,000 shares; 2024Q4: 895,000 shares; 2025Q1: 895,000 shares; 2025Q2: 895,000 shares; 2025Q3: 895,000 shares 895,000$100K0.02%0Timeline
CLDICALIDI BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,042 shares 1,042$1.58K<0.01%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
SPYSTATE STR SPDR S&P 500 ETF T SHSput1,207,500$804M+34,000
IWMISHARES TR SHSput1,617,000$391M+1,032,000

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
LLYVKLIBERTY MEDIA CORP DEL537,051$43.6Mshares
SUMMIT HEALTHCARE ACQUISITI…SUMMIT HEALTHCARE ACQUISITION489,999$19.6Kshares
CALIDI BIOTHERAPEUTICS INCCALIDI BIOTHERAPEUTICS INC12,499$2.88Kshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000904454-25-000583 base2025-11-13acceptance time not in the bulk data set